TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -0 | -3 | -1 | -31 | -36 | -30 | -17 |
| S | %wins | 67 | 100 | 67 | 100 | 100 | 100 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/9/11 06:09 | 6/6/11 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Geller Matthew | NY | D | S.m | -244 | 24.40 | 0 | -10 | -100 | 0 | D | 23 | 16 | 6 | -7 | 2 | 6 | 6 | 4 | -1 | -7 | 1 | -29 | -35 | -27 | |
5/26/11 19:21 | 5/24/11 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Geller Matthew | NY | D | S | -185 | 24.08 | 0 | -8 | -44 | 10 | D | 19 | -12 | 1 | -12 | -2 | 1 | 0 | -4 | 1 | 0 | 0 | -32 | -39 | -29 | |
5/23/11 18:31 | 5/19/11 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Geller Matthew | NY | D | S.m | -295 | 24.01 | 0 | -12 | -41 | 18 | D | 24 | -9 | 2 | -8 | -2 | 0 | 6 | 5 | -1 | -2 | -3 | -33 | -34 | -33 | |
4/16/10 14:11 | 4/15/10 | BSTC | Biospecifics Technologies Corp | DE | Health | Drug | Pharmaceutical Preparations | Geller Matthew | NY | D | M.d | 570 | 19.00 | 0 | 30 | New | 30 | D | 168 | 56 | -9 | 4 | 6 | 4 | 4 | 4 | 5 | 3 | -7 | -33 | -11 | -22 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |